Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix Tetra with or without Meningitec in healthy toddlers
2011-001608-37Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in measles, mumps, rubella and 2 more comparing Priorix Tetra alone, Priorix Tetra + Meningitec and Meningitec alone (3 arms). Primary endpoints: MMRV immunogenicity non-inferiority and MenC immunogenicity non-inferiority. Started Feb 2012; status: completed.
02
Drugs
GSK208136Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
measlesmumpsrubellachickenpoxmeningococcal disease
Beyond the preview
Go deeper on 2011-001608-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001608-37.